The partial reinforcement extinction effect in humans: effects of schizophrenia, schizotypy and low doses of amphetamine. 2002

Nicola S Gray, and Alan D Pickering, and Robert J Snowden, and David R Hemsley, and Jeffrey A Gray
School of Psychology, Cardiff University, PO Box 901, Park Place, South Wales, UK. grayns@cardiff.ac.uk

The partial reinforcement extinction effect (PREE) was studied in human subjects. It has been suggested that the PREE depends on neural mechanisms critical to the cognitive dysfunction which underlines acute schizophrenia. We therefore predicted that the PREE should be reduced, through decreased resistance to extinction in the partial reinforcement (PR) condition, in various types of individual: (a) healthy volunteers given low doses of oral amphetamine; (b) those in the acute (but not chronic) phase of a schizophrenic illness and; (c) healthy volunteers with high scores on personality measures of schizotypy. Despite obtaining robust demonstrations of PREE in all experiments, none of these predictions were confirmed. A single, low dose, of amphetamine had no effect on either continuous reinforcement (CR) or partial reinforcement (PR). Acute and chronic schizophrenic patients showed a reduced PREE compared to controls. However this was due to increased resistance to extinction in the CR groups. Finally, high schizotypy scores were associated with greater PREE, attributable to both decreased extinction in the CR condition and increased extinction in the PR condition. The results of these experiments on human PREE provide no support that PREE is a valid paradigm with which to explore the cognitive dysfunction underlying schizophrenia.

UI MeSH Term Description Entries
D008297 Male Males
D010551 Personality Behavior-response patterns that characterize the individual. Personalities
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D012055 Reinforcement Schedule A schedule prescribing when the subject is to be reinforced or rewarded in terms of temporal interval in psychological experiments. The schedule may be continuous or intermittent. Reinforcement Schedules,Schedule, Reinforcement,Schedules, Reinforcement
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005108 Extinction, Psychological The procedure of presenting the conditioned stimulus without REINFORCEMENT to an organism previously conditioned. It refers also to the diminution of a conditioned response resulting from this procedure. Psychological Extinction,Extinction (Psychology),Extinctions (Psychology),Extinctions, Psychological,Psychological Extinctions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

Nicola S Gray, and Alan D Pickering, and Robert J Snowden, and David R Hemsley, and Jeffrey A Gray
January 1985, Psychopharmacology,
Nicola S Gray, and Alan D Pickering, and Robert J Snowden, and David R Hemsley, and Jeffrey A Gray
January 1989, Pharmacology, biochemistry, and behavior,
Nicola S Gray, and Alan D Pickering, and Robert J Snowden, and David R Hemsley, and Jeffrey A Gray
January 1989, Pharmacology, biochemistry, and behavior,
Nicola S Gray, and Alan D Pickering, and Robert J Snowden, and David R Hemsley, and Jeffrey A Gray
October 2022, Journal of experimental psychology. Animal learning and cognition,
Nicola S Gray, and Alan D Pickering, and Robert J Snowden, and David R Hemsley, and Jeffrey A Gray
September 2017, Behaviour research and therapy,
Nicola S Gray, and Alan D Pickering, and Robert J Snowden, and David R Hemsley, and Jeffrey A Gray
January 1986, Psychopharmacology,
Nicola S Gray, and Alan D Pickering, and Robert J Snowden, and David R Hemsley, and Jeffrey A Gray
March 1957, Journal of experimental psychology,
Nicola S Gray, and Alan D Pickering, and Robert J Snowden, and David R Hemsley, and Jeffrey A Gray
June 1987, Pharmacology, biochemistry, and behavior,
Nicola S Gray, and Alan D Pickering, and Robert J Snowden, and David R Hemsley, and Jeffrey A Gray
November 1977, Pharmacology, biochemistry, and behavior,
Nicola S Gray, and Alan D Pickering, and Robert J Snowden, and David R Hemsley, and Jeffrey A Gray
January 1985, Experimental brain research,
Copied contents to your clipboard!